top of page


Theranos 2.0? Why the Ghost of Holmes Still Haunts Health Tech
In the aftermath of one of Silicon Valley’s most infamous frauds, the biotech sector finds itself confronting an uncomfortable echo....

Rich Washburn
Jun 43 min read


Beyond the Tariff Wall: Strategic Implications of a Post‑China Supply Chain
With U.S. tariffs on Chinese goods now reaching up to 245 percent , the world’s largest trading relationship has crossed a structural...
-
Apr 193 min read
bottom of page